227
Views
6
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Disease and Cervical Cancer Screening Rate

Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine

, , &
Pages 656-658 | Received 18 Oct 2017, Accepted 09 Dec 2017, Published online: 23 Feb 2018

References

  • Jess T, Horváth-Puhó E, Fallingborg J, et al. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol 2013; 108:1869–76.
  • Rahier JF, Magro F, Abreu C, European Crohn’s and Colitis Organisation (ECCO), et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014;8:443–68.
  • Sifuentes H, Kane S. Monitoring for extra-intestinal cancers in IBD. Curr Gastroenterol Rep 2015;17:42.
  • Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008;103:631–6.
  • Allegretti JR, Barnes EL, Cameron A. Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis. Inflamm Bowel Dis 2015;21:1089–97.
  • Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol 2012;120:1222–38.
  • Saslow D, Solomon D, Lawson HW, ACS-ASCCP-ASCP Cervical Cancer Guideline Committee, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147–72.
  • Magro F, Peyrin-Biroulet L, Sokol H, et al. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). J Crohns Colitis 2014;8:31–44.
  • Jacobson DL, Bousvaros A, Ashworth L, et al. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1441–9.
  • Rungoe C, Simonsen J, Riis L, et al. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study. Clin Gastroenterol Hepatol 2015;13:693–700.e1.
  • Long MD, Porter CQ, Sandler RS, Kappelman MD. Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:549–53.
  • Walsh AJ, Weltman M, Burger D, et al. Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2013;7:e449–56.
  • R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
  • Singh H, Demers AA, Nugent Z, et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology 2009;136:451–8.
  • Greywoode RC, Fine SD, Borum ML. Appropriate cervical cancer screening remains essential: the case of women with inflammatory bowel disease. Am J Obstet Gynecol 2012;206:e6–7.
  • Ellul P, Zammita SC, Katsanos KH, et al. Perception of reproductive health in women with inflammatory bowel disease. J Crohns Colitis 2016;10:886–91.
  • de Bie RP, Vergers-Spooren HC, Massuger LF, et al. Patients with cervical cancer: why did screening not prevent these cases? Am J Obstet Gynecol 2011;205:64.e1–7.
  • International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885–91.
  • Polish National Immunisation Programme 2016. Directive Ministry of Health. Available from: http://dziennikmz.mz.gov.pl/DUM_MZ/2015/63/akt.pdf [last accessed 14 Jun 2017].
  • Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016;22:7625–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.